ArticleCureus2025

Assessing Renoprotective Effects of Empagliflozin and Telmisartan Combination Therapy in Non-albuminuric Diabetic Nephropathy: A Retrospective Cohort Study.

Anand Acharya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.